$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Brain metastases: an overview 원문보기

CNS oncology, v.4 no.1, 2015년, pp.37 - 46  

Bertolini, F (Department of Oncology, Azienda Ospedaliero-Universitaria Modena, via Del Pozzo, 71, 41124, Modena, Italy) ,  Spallanzani, A (Department of Oncology, Azienda Ospedaliero-Universitaria Modena, via Del Pozzo, 71, 41124, Modena, Italy) ,  Fontana, A (Department of Oncology, Azienda Ospedaliero-Universitaria Modena, via Del Pozzo, 71, 41124, Modena, Italy) ,  Depenni, R (Department of Oncology, Azienda Ospedaliero-Universitaria Modena, via Del Pozzo, 71, 41124, Modena, Italy) ,  Luppi, G (Department of Oncology, Azienda Ospedaliero-Universitaria Modena, via Del Pozzo, 71, 41124, Modena, Italy)

Abstract AI-Helper 아이콘AI-Helper

SUMMARY So far brain metastases represent a critical stage of a disease course and the frequency is increasing over the years. The treatment of brain metastases should be individualized for each patient: in case of single brain metastasis, surgery or radiosurgery should be considered as first opti...

참고문헌 (81)

  1. Nieder, Carsten, Spanne, Oddvar, Mehta, Minesh P., Grosu, Anca L., Geinitz, Hans. Presentation, patterns of care, and survival in patients with brain metastases. Cancer, vol.117, no.11, 2505-2512.

  2. Eichler, April F., Loeffler, Jay S.. Multidisciplinary Management of Brain Metastases. The oncologist, vol.12, no.7, 884-898.

  3. Christiaans, Maria H., Kelder, Johannes C., Arnoldus, Edo P. J., Tijssen, Cees C.. Prediction of intracranial metastases in cancer patients with headache. Cancer, vol.94, no.7, 2063-2068.

  4. Davey, Phillip. Brain Metastases : Treatment Options to Improve Outcomes. Cns drugs, vol.16, no.5, 325-338.

  5. Tosoni, Alicia, Franceschi, Enrico, Brandes, Alba A.. Chemotherapy in breast cancer patients with brain metastases: Have new chemotherapic agents changed the clinical outcome?. Critical reviews in oncology/hematology, vol.68, no.3, 212-221.

  6. Gaspar, Laurie E., Scott, Charles, Murray, Kevin, Curran, Walter. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. International journal of radiation oncology, biology, physics, vol.47, no.4, 1001-1006.

  7. Sperduto, Paul W., Berkey, Brian, Gaspar, Laurie E., Mehta, Minesh, Curran, Walter. A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database. International journal of radiation oncology, biology, physics, vol.70, no.2, 510-514.

  8. Nieder, Carsten, Marienhagen, Kirsten, Geinitz, Hans, Molls, Michael. Validation of the graded prognostic assessment index for patients with brain metastases. Acta oncologica, vol.48, no.3, 457-459.

  9. Sperduto, Paul W., Kased, Norbert, Roberge, David, Xu, Zhiyuan, Shanley, Ryan, Luo, Xianghua, Sneed, Penny K., Chao, Samuel T., Weil, Robert J., Suh, John, Bhatt, Amit, Jensen, Ashley W., Brown, Paul D., Shih, Helen A., Kirkpatrick, John, Gaspar, Laurie E., Fiveash, John B., Chiang, Veronica, Knisely, Jonathan P.S., Sperduto, Christina Maria, Lin, Nancy, Mehta, Minesh. Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.30, no.4, 419-425.

  10. Arnold, Susanne M., Patchell, Roy A.. DIAGNOSIS AND MANAGEMENT OF BRAIN METASTASES. Hematology/oncology clinics of North America, vol.15, no.6, 1085-1108.

  11. Schellinger, Peter D., Meinck, Hans M., Thron, Armin. Diagnostic Accuracy of MRI Compared to CCT in Patients with Brain Metastases. Journal of neuro-oncology, vol.44, no.3, 275-281.

  12. Kaal, Evert C. A., Taphoorn, Martin J. B., Vecht, Charles J.. Symptomatic management and imaging of brain metastases. Journal of neuro-oncology, vol.75, no.1, 15-20.

  13. Østergaard, Leif, Hochberg, Fred H., Rabinov, James D., Sorensen, A. Gregory, Lev, Michael, Kim, Lyndon, Weisskoff, Robert M., Gonzalez, R. Gilberto, Gyldensted, Carsten, Rosen, Bruce R.. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. Journal of neurosurgery, vol.90, no.2, 300-305.

  14. Vecht, Ch J., Hovestadt, A., Verbiest, H.B.C., van Vliet, J. J., van Putten, W. L.J.. Dose‐effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors : A randomized study of doses of 4, 8, and 16 mg per day. Neurology, vol.44, no.4, 675-675.

  15. Glantz, M.J., Cole, B.F., Forsyth, P.A., Recht, L.D., Wen, P.Y., Chamberlain, M.C., Grossman, S.A., Cairncross, J.G.. Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED] : Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, vol.54, no.10, 1886-1893.

  16. Mikkelsen, Tom, Paleologos, Nina A., Robinson, Paula D., Ammirati, Mario, Andrews, David W., Asher, Anthony L., Burri, Stuart H., Cobbs, Charles S., Gaspar, Laurie E., Kondziolka, Douglas, Linskey, Mark E., Loeffler, Jay S., McDermott, Michael, Mehta, Minesh P., Olson, Jeffrey J., Patchell, Roy A., Ryken, Timothy C., Kalkanis, Steven N.. The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of neuro-oncology, vol.96, no.1, 97-102.

  17. Tosoni, Alicia, Ermani, Mario, Brandes, Alba A.. The pathogenesis and treatment of brain metastases: a comprehensive review. Critical reviews in oncology/hematology, vol.52, no.3, 199-215.

  18. Kalkanis, Steven N., Kondziolka, Douglas, Gaspar, Laurie E., Burri, Stuart H., Asher, Anthony L., Cobbs, Charles S., Ammirati, Mario, Robinson, Paula D., Andrews, David W., Loeffler, Jay S., McDermott, Michael, Mehta, Minesh P., Mikkelsen, Tom, Olson, Jeffrey J., Paleologos, Nina A., Patchell, Roy A., Ryken, Timothy C., Linskey, Mark E.. The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of neuro-oncology, vol.96, no.1, 33-43.

  19. 10.1002/(SICI)1097-0142(19961001)78:7<1470::AID-CNCR14>3.0.CO;2-X 

  20. Patchell, Roy A., Tibbs, Phillip A., Walsh, John W., Dempsey, Robert J., Maruyama, Yosh, Kryscio, Richard J., Markesbery, William R., Macdonald, John S., Young, Byron. A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain. The New England journal of medicine, vol.322, no.8, 494-500.

  21. Vecht, Charles J., Haaxma‐Reiche, Hanny, Noordijk, Evert M., Padberg, George W., Voormolen, Joan H. C., Hoekstra, Foppe H., Tans, Joseph Th. J., Lambooij, Nanno, Metsaars, Jan A. L., Wattendorff, A. Rolf, Brand, Ronald, Hermans, Jo. Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery. Annals of neurology, vol.33, no.6, 583-590.

  22. Warnick, Ronald E., Darakchiev, Borimir J., Breneman, John C.. Stereotactic Radiosurgery for Patients with Solid Brain Metastases: Current Status. Journal of neuro-oncology, vol.69, no.1, 125-137.

  23. Linskey, Mark E., Andrews, David W., Asher, Anthony L., Burri, Stuart H., Kondziolka, Douglas, Robinson, Paula D., Ammirati, Mario, Cobbs, Charles S., Gaspar, Laurie E., Loeffler, Jay S., McDermott, Michael, Mehta, Minesh P., Mikkelsen, Tom, Olson, Jeffrey J., Paleologos, Nina A., Patchell, Roy A., Ryken, Timothy C., Kalkanis, Steven N.. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of neuro-oncology, vol.96, no.1, 45-68.

  24. Nieder, Carsten, Grosu, Anca L, Gaspar, Laurie E. Stereotactic radiosurgery (SRS) for brain metastases: a systematic review. Radiation oncology, vol.9, 155-155.

  25. Gerosa, Massimo, Nicolato, Antonio, Foroni, Roberto. The role of gamma knife radiosurgery in the treatment of primary and metastatic brain tumors. Current opinion in oncology, vol.15, no.3, 188-196.

  26. Peterson, Halloran E., Larson, Erik W., Fairbanks, Robert K., MacKay, Alexander R., Lamoreaux, Wayne T., Call, Jason A., Carlson, Jonathan D., Ling, Benjamin C., Demakas, John J., Cooke, Barton S., Peressini, Ben, Lee, Christopher M.. Gamma Knife Treatment of Brainstem Metastases. International journal of molecular sciences, vol.15, no.6, 9748-9761.

  27. Andrews, David W, Scott, Charles B, Sperduto, Paul W, Flanders, Adam E, Gaspar, Laurie E, Schell, Michael C, Werner-Wasik, Maria, Demas, William, Ryu, Janice, Bahary, Jean-Paul, Souhami, Luis, Rotman, Marvin, Mehta, Minesh P, Curran Jr, Walter J. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. The Lancet, vol.363, no.9422, 1665-1672.

  28. Shaw, Edward, Scott, Charles, Souhami, Luis, Dinapoli, Robert, Kline, Robert, Loeffler, Jay, Farnan, Nancy. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. International journal of radiation oncology, biology, physics, vol.47, no.2, 291-298.

  29. Mehta, Minesh P., Tsao, May N., Whelan, Timothy J., Morris, David E., Hayman, James A., Flickinger, John C., Mills, Michael, Rogers, C. Leland, Souhami, Luis. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. International journal of radiation oncology, biology, physics, vol.63, no.1, 37-46.

  30. Patchell, R A, Tibbs, P A, Regine, W F, Dempsey, R J, Mohiuddin, M, Kryscio, R J, Markesbery, W R, Foon, K A, Young, B. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.. JAMA : the journal of the American Medical Association, vol.280, no.17, 1485-1489.

  31. Wiggenraad, R., Kanter, A.V.d., Kal, H.B., Taphoorn, M., Vissers, T., Struikmans, H.. Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, vol.98, no.3, 292-297.

  32. Pollock, Bruce E., Brown, Paul D., Foote, Robert L., Stafford, Scott L., Schomberg, Paula J.. Properly Selected Patients with Multiple Brain Metastases May Benefit from Aggressive Treatment of their Intracranial Disease. Journal of neuro-oncology, vol.61, no.1, 73-80.

  33. Kocher, Martin, Soffietti, Riccardo, Abacioglu, Ufuk, Villà, Salvador, Fauchon, Francois, Baumert, Brigitta G., Fariselli, Laura, Tzuk-Shina, Tzahala, Kortmann, Rolf-Dieter, Carrie, Christian, Hassel, Mohamed Ben, Kouri, Mauri, Valeinis, Egils, van den Berge, Dirk, Collette, Sandra, Collette, Laurence, Mueller, Rolf-Peter. Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.29, no.2, 134-141.

  34. Gaspar, Laurie E., Mehta, Minesh P., Patchell, Roy A., Burri, Stuart H., Robinson, Paula D., Morris, Rachel E., Ammirati, Mario, Andrews, David W., Asher, Anthony L., Cobbs, Charles S., Kondziolka, Douglas, Linskey, Mark E., Loeffler, Jay S., McDermott, Michael, Mikkelsen, Tom, Olson, Jeffrey J., Paleologos, Nina A., Ryken, Timothy C., Kalkanis, Steven N.. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of neuro-oncology, vol.96, no.1, 17-32.

  35. Soffietti, Riccardo, Kocher, Martin, Abacioglu, Ufuk M., Villa, Salvador, Fauchon, François, Baumert, Brigitta G., Fariselli, Laura, Tzuk-Shina, Tzahala, Kortmann, Rolf-Dieter, Carrie, Christian, Ben Hassel, Mohamed, Kouri, Mauri, Valeinis, Egils, van den Berge, Dirk, Mueller, Rolf-Peter, Tridello, Gloria, Collette, Laurence, Bottomley, Andrew. A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.31, no.1, 65-72.

  36. Cochrane Database Syst. Rev. Tsao MN CD003869 4 2012 

  37. Chang, E.L., Wefel, J.S., Hess, K.R., Allen, P.K., Lang, F.F., Kornguth, D.G., Arbuckle, R.B., Swint, J.M., Shiu, A.S., Maor, M.H., Meyers, C.A.. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. The Lancet. Oncology, vol.10, no.11, 1037-1044.

  38. Rades, Dirk, Haatanen, Tiina, Schild, Steven E., Dunst, Juergen. Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases. Cancer, vol.110, no.6, 1345-1350.

  39. Conill, C., Berenguer, J., Vargas, M., López-Soriano, A., Valduvieco, I., Marruecos, J., Vilella, R.. Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol.9, no.9, 590-595.

  40. DeAngelis, Lisa M., Delattre, Jean-Yves, Posner, Jerome B.. Radiation‐induced dementia in patients cured of brain metastases. Neurology, vol.39, no.6, 789-789.

  41. Li, Jing, Bentzen, Soren M., Renschler, Markus, Mehta, Minesh P.. Regression After Whole-Brain Radiation Therapy for Brain Metastases Correlates With Survival and Improved Neurocognitive Function. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.25, no.10, 1260-1266.

  42. Mehta, Minesh P., Shapiro, William R., Phan, See C., Gervais, Radj, Carrie, Christian, Chabot, Pierre, Patchell, Roy A., Glantz, Michael J., Recht, Lawrence, Langer, Corey, Sur, Ranjan K., Roa, Wilson H., Mahe, Marc A., Fortin, Andre, Nieder, Carsten, Meyers, Christina A., Smith, Jennifer A., Miller, Richard A., Renschler, Markus F.. Motexafin Gadolinium Combined With Prompt Whole Brain Radiotherapy Prolongs Time to Neurologic Progression in Non–Small-Cell Lung Cancer Patients With Brain Metastases: Results of a Phase III Trial. International journal of radiation oncology, biology, physics, vol.73, no.4, 1069-1076.

  43. Walbert, Tobias, Gilbert, Mark R.. The role of chemotherapy in the treatment of patients with brain metastases from solid tumors. International journal of clinical oncology, vol.14, no.4, 299-306.

  44. 10.1002/(SICI)1097-0142(19990401)85:7<1599::AID-CNCR23>3.0.CO;2-# 

  45. Semin. Oncol. Postmus PE 89 19 2 1992 

  46. Bartolotti, Marco, Franceschi, Enrico, Brandes, Alba Ariela. EGF receptor tyrosine kinase inhibitors in the treatment of brain metastases from non-small-cell lung cancer. Expert review of anticancer therapy, vol.12, no.11, 1429-1435.

  47. Avril, M.F., Aamdal, S., Grob, J.J., Hauschild, A., Mohr, P., Bonerandi, J.J., Weichenthal, M., Neuber, K., Bieber, T., Gilde, K., Guillem Porta, V., Fra, J., Bonneterre, J., Saïag, P., Kamanabrou, D., Pehamberger, H., Sufliarsky, J., Gonzalez Larriba, J.L., Scherrer, A., Menu, Y.. Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.22, no.6, 1118-1125.

  48. Cotto, C., Berille, J., Souquet, P.J., Riou, R., Croisile, B., Turjman, F., Giroux, B., Brune, J., Trillet-Lenoir, V.. A phase II trial of fotemustine and cisplatin in central nervous system metastases from non-small cell lung cancer. European journal of cancer, vol.32, no.1, 69-71.

  49. Agarwala, Sanjiv S., Kirkwood, John M., Gore, Martin, Dreno, Brigitte, Thatcher, Nicholas, Czarnetski, Beate, Atkins, Michael, Buzaid, Antonio, Skarlos, Dimosthenis, Rankin, Elaine M.. Temozolomide for the Treatment of Brain Metastases Associated With Metastatic Melanoma: A Phase II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.22, no.11, 2101-2107.

  50. Guerrieri, Mario, Wong, Kevin, Ryan, Gail, Millward, Michael, Quong, George, Ball, David L.. A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung. Lung cancer : Journal of the International Association for the Study of Lung Cancer, vol.46, no.1, 107-111.

  51. Verger, Eugènia, Gil, Miguel, Yaya, Ricardo, Viñolas, Núria, Villà, Salvador, Pujol, Teresa, Quintó, Llorenç, Graus, Francesc. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: A phase II randomized trial. International journal of radiation oncology, biology, physics, vol.61, no.1, 185-191.

  52. Antonadou, D., Paraskevaidis, M., Sarris, G., Coliarakis, N., Economou, I., Karageorgis, P., Throuvalas, N.. Phase II Randomized Trial of Temozolomide and Concurrent Radiotherapy in Patients With Brain Metastases. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.20, no.17, 3644-3650.

  53. 10.1159/000061217 

  54. Aupérin, Anne, Arriagada, Rodrigo, Pignon, Jean-Pierre, Le Péchoux, Cécile, Gregor, Anna, Stephens, Richard J., Kristjansen, Paul E.G., Johnson, Bruce E., Ueoka, Hiroshi, Wagner, Henry, Aisner, Joseph. Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission. The New England journal of medicine, vol.341, no.7, 476-484.

  55. Papadatos-Pastos, Dionysis, Banerji, Udai. Revisiting the role of molecular targeted therapies in patients with brain metastases. Journal of neuro-oncology, vol.105, no.3, 467-474.

  56. Lin, Nancy U.. Targeted Therapies in Brain Metastases. Current treatment options in neurology, vol.16, no.1, 276-.

  57. Besse, Benjamin, Lasserre, Susan F., Compton, Peter, Huang, Jane, Augustus, Stella, Rohr, Ulrich-Peter. Bevacizumab Safety in Patients with Central Nervous System Metastases. Clinical Cancer research : an official journal of the American Association for Cancer Research, vol.16, no.1, 269-278.

  58. De Braganca, Kevin C., Janjigian, Yelena Y., Azzoli, Christopher G., Kris, Mark G., Pietanza, Maria C., Nolan, Craig P., Omuro, Antonio M., Holodny, Andrei I., Lassman, Andrew B.. Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer. Journal of neuro-oncology, vol.100, no.3, 443-447.

  59. Lu, Suat-Jin, Rodriguez-Justo, Manuel, Read, Samantha, Bomanji, Jamshed B.. Metabolic-Morphologic Discordant Solitary Skeletal Muscle Metastasis on [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scan in Synchronous Lung and Esophageal Cancer: A Lesson. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.30, no.8, e97-e101.

  60. Lin, Chia-Chi, Wang, Jann-Yuan, Pu, Yeong-Shiau. Reply to S. Vale. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.31, no.20, 2634-2635.

  61. Lévy, C., Allouache, D., Lacroix, J., Dugué, A. E., Supiot, S., Campone, M., Mahe, M., Kichou, S., Leheurteur, M., Hanzen, C., Dieras, V., Kirova, Y., Campana, F., Le Rhun, E., Gras, L., Bachelot, T., Sunyach, M.-P., Hrab, I., Geffrelot, J., Gunzer, K., Constans, J.-M., Grellard, J.-M., Clarisse, B., Paoletti, X.. REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours. Annals of oncology : official journal of the European Society for Medical Oncology, vol.25, no.12, 2351-2356.

  62. Franceschi, Enrico, Bartolotti, Marco, Poggi, Rosalba, Battista, Monica Di, Palleschi, Dario, Brandes, Alba A. The role of systemic and targeted therapies in brain metastases. Expert review of anticancer therapy, vol.14, no.1, 93-103.

  63. Margolin, K., Ernstoff, M.S., Hamid, O., Lawrence, D., McDermott, D., Puzanov, I., Wolchok, J.D., Clark, J.I., Sznol, M., Logan, T.F., Richards, J., Michener, T., Balogh, A., Heller, K.N., Hodi, F.S.. Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial. The Lancet. Oncology, vol.13, no.5, 459-465.

  64. Gore, Martin E., Hariharan, Subramanian, Porta, Camillo, Bracarda, Sergio, Hawkins, Robert, Bjarnason, Georg A., Oudard, Stéphane, Lee, Se‐Hoon, Carteni, Giacomo, Nieto, Alejandra, Yuan, Jinyu, Szczylik, Cezary. Sunitinib in metastatic renal cell carcinoma patients with brain metastases. Cancer, vol.117, no.3, 501-509.

  65. Novello, Silvia, Camps, Carlos, Grossi, Francesco, Mazieres, Julien, Abrey, Lauren, Vernejoux, Jean-Marc, Thall, Aron, Patyna, Shem, Usari, Tiziana, Wang, Zhixiao, Chao, Richard C., Scagliotti, Giorgio. Phase II Study of Sunitinib in Patients with Non-small Cell Lung Cancer and Irradiated Brain Metastases. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol.6, no.7, 1260-1266.

  66. Massard, C., Zonierek, J., Gross-Goupil, M., Fizazi, K., Szczylik, C., Escudier, B.. Incidence of brain metastases in renal cell carcinoma treated with sorafenib. Annals of oncology : official journal of the European Society for Medical Oncology, vol.21, no.5, 1027-1031.

  67. Ceresoli, G. L., Cappuzzo, F., Gregorc, V., Bartolini, S., Crinò, L., Villa, E.. Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial. Annals of oncology : official journal of the European Society for Medical Oncology, vol.15, no.7, 1042-1047.

  68. Wu, Chi, Li, Yun Long, Wang, Zhao Meng, Li, Zhang, Zhang, Tong Xiao, Wei, Zhong. Gefitinib as palliative therapy for lung adenocarcinoma metastatic to the brain. Lung cancer : Journal of the International Association for the Study of Lung Cancer, vol.57, no.3, 359-364.

  69. Welsh, James W., Komaki, Ritsuko, Amini, Arya, Munsell, Mark F., Unger, Wyatt, Allen, Pamela K., Chang, Joe Y., Wefel, Jeffrey S., McGovern, Susan L., Garland, Linda L., Chen, Su S., Holt, Jamie, Liao, Zhongxing, Brown, Paul, Sulman, Erik, Heymach, John V., Kim, Edward S., Stea, Baldassarre. Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non–Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.31, no.7, 895-902.

  70. Altavilla, Giuseppe, Arrigo, Carmela, Santarpia, Maria Carmela, Galletti, Giuseppe, Picone, Giovanni, Marabello, Grazia, Tomasello, Chiara, Pitini, Vincenzo V.. Erlotinib therapy in a patient with non-small-cell lung cancer and brain metastases. Journal of neuro-oncology, vol.90, no.1, 31-33.

  71. J. Clin. Oncol. Paz-Ares L 24 369 2006 

  72. on behalf of the Spanish Lung Cancer Group in collaboration with the Groupe Francais de Pneumo-Cancerologie and the Associazione Italiana Oncologia Toracica, Rosell, R., Carcereny, E., Gervais, R., Vergnenegre, A., Massuti, B., Felip, E., Palmero, R., Garcia-Gomez, R., Pallares, C., Sanchez, J.M., Porta, R., Cobo, M., Garrido, P., Longo, F., Moran, T., Insa, A., De Marinis, F., Corre, R., Bover, I., Illiano, A., Dansin, E., de Castro, J., Milella, M., Reguart, N., Altavilla, G., Jimenez, U., Provencio, M., Moreno, M.A., Terrasa, J., Munoz-Langa, J., Valdivia, J., Isla, D., Domine, M., Molinier, O., Mazieres, J., Baize, N., Garcia-Campelo, R., Robinet, G., Rodriguez-Abreu, D., Lopez-Vivanco, G., Gebbia, V., Ferrera-Delgado, L., Bombaron, P., Bernabe, R., Bearz, A., Artal, A., Cortesi, E., Rolfo, C., Sanchez-Ronco, M., Drozdowskyj, A., Queralt, C., de Aguirre, I., Ramirez, J.L., Sanchez, J.J., Molina, M.A., Taron, M., Paz-Ares, L.. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. The Lancet. Oncology, vol.13, no.3, 239-246.

  73. Lukas, Rimas V, Lesniak, Maciej S, Salgia, Ravi. Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches. CNS oncology, vol.3, no.1, 61-75.

  74. Musolino, Antonino, Ciccolallo, Laura, Panebianco, Michele, Fontana, Elisa, Zanoni, Daniele, Bozzetti, Cecilia, Michiara, Maria, Silini, Enrico Maria, Ardizzoni, Andrea. Multifactorial central nervous system recurrence susceptibility in patients with HER2‐positive breast cancer. Cancer, vol.117, no.9, 1837-1846.

  75. Braccini, A.L., Azria, D., Thezenas, S., Romieu, G., Ferrero, J.M., Jacot, W.. Prognostic factors of brain metastases from breast cancer: Impact of targeted therapies. The Breast : official journal of the European Society of Mastology, vol.22, no.5, 993-998.

  76. Lin, Nancy U., Carey, Lisa A., Liu, Minetta C., Younger, Jerry, Come, Steven E., Ewend, Matthew, Harris, Gordon J., Bullitt, Elizabeth, Van den Abbeele, Annick D., Henson, John W., Li, Xiaochun, Gelman, Rebecca, Burstein, Harold J., Kasparian, Elizabeth, Kirsch, David G., Crawford, Ann, Hochberg, Fred, Winer, Eric P.. Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.26, no.12, 1993-1999.

  77. Lin, Nancy U., Eierman, Wolfgang, Greil, Richard, Campone, Mario, Kaufman, Bella, Steplewski, Klaudia, Lane, Stephen R., Zembryki, Denise, Rubin, Stephen D., Winer, Eric P.. Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases. Journal of neuro-oncology, vol.105, no.3, 613-620.

  78. Bachelot, T., Romieu, G., Campone, M., Dieras, V., Cropet, C., Dalenc, F., Jimenez, M., Le Rhun, E., Pierga, J.Y., Goncalves, A., Leheurteur, M., Domont, J., Gutierrez, M., Cure, H., Ferrero, J.M., Labbe-Devilliers, C.. Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study. The Lancet. Oncology, vol.14, no.1, 64-71.

  79. Rochet, N.M., Dronca, R.S., Kottschade, L.A., Chavan, R.N., Gorman, B., Gilbertson, J.R., Markovic, S.N.. Melanoma Brain Metastases and Vemurafenib: Need for Further Investigation. Mayo Clinic proceedings, vol.87, no.10, 976-981.

  80. J. Clin. Oncol. Dummer R 29 2011 10.1200/jco.2011.29.15_suppl.8548 

  81. Ann. Oncol. Long GV 21 2010 

관련 콘텐츠

오픈액세스(OA) 유형

GREEN

저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로